Compliant DOT Drug & Alcohol Testing for Commercial Carriers

Employers with CDL drivers performing safety-sensitive functions must maintain a drug testing program under 49 CFR Part 382. This includes written policies, MRO reviews, and Clearinghouse reporting. Missing key program elements can lead to violations during an audit or compliance review.

Random draws slip during peak season. MRO backlogs build up. Clearinghouse queries get forgotten. Most violations? Gaps in the system, not carriers dodging the rules.

The 6 Required Drug and Alcohol Testing Categories

DOT drug and alcohol testing programs include six required testing categories. Missing or mismanaging any of these categories can lead to violations during an audit.

This trips up more carriers than you'd expect: 20 drivers at 50% means 10 selections total for the year. But Jones can get picked three times in Q1 if that's how the draw falls. Random means random. For details on the quarterly draw schedule and selection calculations, see DOT Random Drug Test Frequency. Owner-operators and small fleets that can't run their own random pool should look into a DOT drug testing consortium -- it's the standard compliance method for carriers under 50 drivers.

Where Programs Break Down

Most commercial motor vehicle carriers aren't trying to skip testing entirely. They miss pieces:

• Clearinghouse queries not run before a hire. Pre-employment full queries are mandatory since January 2020. Half the violations we see are from skipped queries or running a limited instead of a full.
• Random draws that fell behind. Q3 and Q4 draws get forgotten during peak season. If you can't show quarterly selections during an audit, the program is deficient.
• Chain of custody forms filed wrong or not at all. The Federal Drug Testing Custody and Control Form (CCF) has to be completed correctly or the test result is invalid.
• No written policy, or a policy that hasn't been updated. 49 CFR 382.601 requires a written policy distributed to every driver. If your policy still references the old testing panel (pre-2018 MDMA addition), it's outdated.
• MIS reports not filed. If FMCSA selects you for annual Management Information System reporting, failure to file is a separate violation.

Having a program isn't enough. Drug and alcohol testing programs are a routine focus during FMCSA compliance reviews. Programs need to stay organized and current to hold up during a compliance review.

What Happens When a CDL Driver Tests Positive for Drugs?

If a driver has a verified positive test result, they must be removed from safety-sensitive functions. The MRO calls to verify -- checking prescriptions, medical conditions, anything that might explain the result. No valid explanation? The result goes to the Clearinghouse and the driver enters the DOT Substance Abuse Professional (SAP) process.

Drivers cannot return to safety-sensitive duties until completing the SAP evaluation and meeting return-to-duty requirements. Most SAP evaluations run 2-6 months. Sometimes longer if the assessment finds issues. For the full timeline from positive result through reinstatement, see What Happens If a CDL Driver Fails a Drug Test.

The DOT 5-Panel Drug Test

DOT drug tests screen for five substance categories and only five: marijuana (THC), cocaine, opiates (codeine, morphine, 6-AM/heroin), amphetamines/methamphetamine (including MDMA, added in 2018), and PCP. This is the standard 5-panel defined in 49 CFR Part 40 Subpart F. Employers can't add substances, can't remove them, and can't substitute their own panel. A "10-panel" or "12-panel" test you might use for company policy doesn't satisfy the DOT requirement -- it has to be the federally specified panel, collected and processed through SAMHSA-certified labs.

One change worth knowing: in 2023, DOT finalized rules permitting oral fluid testing as an alternative specimen type under Part 40, although availability still depends on qualified laboratories and collection sites. The same 5-panel applies, but collection is observed by default (no need for a separate direct-observation protocol), and the detection window is shorter -- generally 24-48 hours vs. 1-3 days for urine. Oral fluid can reduce shy-bladder complications and makes it harder to substitute or adulterate specimens. Not all collection sites offer it yet, but it's a legitimate option under Part 40. For the full breakdown of program setup including specimen types, see DOT Drug Testing Program Requirements.

Clearinghouse II: What Changed in November 2024

The original FMCSA Clearinghouse launched in January 2020 and required carriers to report violations and run queries. Clearinghouse II, effective November 18, 2024, closed the biggest loophole: drivers who tested positive could simply let their CDL sit and never complete return-to-duty. State DMVs had no mechanism to act on Clearinghouse data. Clearinghouse II changed that process significantly.

Under Clearinghouse II, FMCSA transmits violation data directly to state licensing agencies. States must downgrade the CDL of any driver with an unresolved drug or alcohol violation. Drivers with unresolved Clearinghouse prohibitions may face CDL downgrades under applicable state implementation requirements. For carriers, this means the hiring pipeline got a built-in filter: if a candidate's CDL is downgraded, they can't legally drive, period.

The practical impact hits current drivers too. Anyone sitting on an unresolved violation from the past four years who hasn't completed return-to-duty is now at risk of losing their CDL. Carriers should run Clearinghouse queries on their entire roster if they haven't already -- you don't want to find out a driver's CDL was downgraded because they had a violation at a previous employer that never got resolved. For more on what a positive test triggers, see What Happens If a CDL Driver Fails a Drug Test.

Recordkeeping Requirements

FMCSA investigators typically review documentation supporting program compliance. Different records have different retention periods:

For a complete breakdown of what records to keep and for how long, see Drug & Alcohol Testing Recordkeeping.

“Most FMCSA audit failures we see come from recordkeeping gaps -- missing chain of custody forms, expired random draws, or incomplete Clearinghouse queries. The testing itself is the easy part. Keeping the paper trail intact is where carriers fall down.”

What Foley Covers as Your C/TPA

As your C/TPA, Foley supports key components of DOT drug and alcohol testing program administration, including:

• Random pool management. Quarterly draws generated, documented, and tracked
• Collection site network: 10,000+ SAMHSA-certified sites nationwide
• MRO services -- licensed Medical Review Officers review all results per 49 CFR Part 40
• Clearinghouse support: including reporting and query workflows
• Recordkeeping maintained per 49 CFR 382.401 retention schedules

Foley has been managing DOT compliance programs for over three decades. The Dash platform helps teams identify gaps before they become audit issues. Request a demo to see how it works.

DOT Drug & Alcohol Testing Program Guides

• DOT Drug Testing Program Requirements -- complete program setup guide covering testing categories, panel substances, MRO process, and Clearinghouse integration
• DOT Random Drug Test Frequency -- FMCSA 50% annual rate explained, quarterly draw schedule, calculation formula, MIS reporting
• What Happens If a CDL Driver Fails a Drug Test? -- full timeline from positive test through SAP evaluation, return-to-duty, and Clearinghouse II CDL downgrade
• DOT SAP Program Guide -- SAP qualifications under 49 CFR 40.281, evaluation process, treatment types, and follow-up testing
• Return-to-Duty Process & Recordkeeping -- what RTD requires and how to automate compliance
• Drug & Alcohol Testing Recordkeeping -- what records FMCSA inspectors require and how long to keep them
• DOT Drug Testing Violations & Penalties -- FMCSA violations, fine examples, and how to avoid them
• DOT Drug Testing Consortium -- managed random testing pool enrollment for carriers and owner-operators